Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05665_nanopub.RAf0f1xDrmHLHHUTVRdMGRQ_XS6vMgh1XFdMdwTcHOAlQ#assertion>. }
Showing items 1 to 16 of
16
with 100 items per page.
- drugbank:DB05665 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05665 label "SCH-503034 [drugbank:DB05665]" assertion.
- drugbank:DB05665 seeAlso DB05665 assertion.
- drugbank:DB05665 identifier "drugbank:DB05665" assertion.
- drugbank:DB05665 description "SCH-503034 is an investigational oral hepatitis C protease inhibitor. SCH-503034 is being evaluated in a large Phase II study in combination with PEG-INTRON(R) (peginterferon alfa-2b) for the treatment of patients chronically infected with hepatitis C virus (HCV) genotype 1 who were nonresponders to peginterferon and ribavirin combination therapy. It is being developed by the Schering-Plough Corporation." assertion.
- drugbank:DB05665 title "SCH-503034" assertion.
- drugbank:DB05665 bio2rdf_vocabulary:identifier "DB05665" assertion.
- drugbank:DB05665 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05665 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05665" assertion.
- drugbank:DB05665 bio2rdf_vocabulary:x-identifiers.org DB05665 assertion.
- drugbank:DB05665 drugbank_vocabulary:drugbank-id "DB05665" assertion.
- drugbank:DB05665 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05665 drugbank_vocabulary:x-chemspider chemspider:8499830 assertion.
- drugbank:DB05665 drugbank_vocabulary:x-pubchemcompound pubchem.compound:10324367 assertion.
- drugbank:DB05665 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:15333889 assertion.
- drugbank:DB05665 drugbank_vocabulary:x-bindingdb bindingdb:12311 assertion.